Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v2.4.0.6
Consolidated Balance Sheets (USD $)
Nov. 30, 2011
Nov. 30, 2010
ASSETS    
Cash and cash equivalents $ 6,305,095 $ 8,369,537 [1]
Restricted cash 2,700,000 200,000 [1]
Marketable securities and other investments 1,002,000 1,132,000 [1]
Accounts receivable (net of allowance for doubtful accounts of $942,533 and $783,354, respectively) 3,059,126 2,356,279 [1]
Deferred tax assets 209,919 167,919 [1]
Prepaid expenses and other current assets 777,284 647,510 [1]
Total current assets 14,053,424 12,873,245 [1]
Property and Equipment-net 1,540,239 2,222,168 [1]
Other Assets    
Marketable securities and other investments 6,404 6,404 [1]
Investment in Saneron CCEL Therapeutics, Inc. 684,000 684,000 [1]
Long-term receivable, net 1,115,423  
Deposits and other assets, net 558,254 756,280 [1]
Deferred tax assets, less current portion 1,509,000 1,551,000 [1]
Total other assets 3,873,081 2,997,684 [1]
Total assets 19,466,744 18,093,097 [1]
LIABILITIES AND STOCKHOLDERS' DEFICIT    
Accounts payable 1,005,240 1,053,186 [1]
Accrued expenses 2,316,875 1,621,221 [1]
Short-term liability-revenue sharing agreements 900,000  
Short-term deferred consulting obligation 72,183 110,872 [1]
Deferred revenue 6,269,148 5,472,332 [1]
Total current liabilities 10,563,446 8,257,611 [1]
Other Liabilities    
Deferred revenue, net of current portion 8,513,686 7,015,118 [1]
Long-term liability-revenue sharing agreements 2,850,000 3,750,000 [1]
Long-term deferred consulting obligation   72,183 [1]
Total other liabilities 11,363,686 10,837,301 [1]
Commitments and Contingencies       [1]
Stockholders' Deficit    
Preferred stock ($.01 par value, 500,000 authorized and none issued)       [1]
Common stock ($.01 par value, 20,000,000 authorized; 11,853,227 issued and outstanding as of November 30, 2011 and 11,752,574 issued and outstanding as of November 30, 2010) 118,532 117,526 [1]
Additional paid-in capital 25,350,483 24,808,591 [1]
Treasury stock, at cost (484,535) (484,535) [1]
Accumulated other comprehensive loss   (94,055) [1]
Accumulated deficit (27,444,868) (25,349,342) [1]
Total stockholders' deficit (2,460,388) (1,001,815) [1]
Total liabilities and stockholders' deficit $ 19,466,744 $ 18,093,097 [1]
[1] See Note 15, Retrospective Adoption of New Accounting Principle